The Latin America, Middle East and Africa RNA Based Therapeutic Market would witness market growth of 17.2% CAGR during the forecast period (2021-2027).
RNA therapies and vaccines that have been given orphan classification by regulatory agencies have a lot of pricing flexibility. Developers have benefited from this, as well as regulatory exclusivity. The absence of other treatment alternatives for rare disorders also aided the expansion of RNA-based medicines and vaccines. Along with these factors, the increased focus of legislative bodies on setting reimbursement laws has accelerated the creation of RNA molecules.
The healthcare industry has been collaborating to bring stability to RNA molecules in the body that has low bioavailability. When coupled with protein/lipid nanoparticles, RNA therapies give improved stability. RNA treatments have been intensively investigated, despite the fact that they are still in the clinical research phase, with the primary goal of treating challenging disorders.
LAMEA is also a lucrative hub for the RNA-based therapeutic market. RNA-based therapeutics is a moderately new class of treatment representing significant potential and growth for the treatment of severe and rare diseases. RNA-based therapeutics are gaining significance for several disease targets, such as HIV, cancer, etc. The growing prevalence of genetic disorders and lack of proper treatment is generating high demand for the development of RNA-based therapeutics. Moreover, South Africa displays a higher requirement for a treatment solution for multiple diseases. Additionally, countries like Brazil and Argentina are already developed. People across these countries comprise significant spending capacity to enhance their lifestyle.
The Brazil market dominated the LAMEA RNA Based Therapeutic Market by Country 2020, and would continue to be a dominant market till 2027; thereby, achieving a market value of $129.9 million by 2027. The Argentina market is anticipated to grow at a CAGR of 17.8% during (2021 - 2027). Additionally, The UAE market would showcase a CAGR of 16.9% during (2021 - 2027).
Based on Type, the market is segmented into RNA Antisense and RNA Interference (RNAi). Based on Application, the market is segmented into Genetic disorders and Auto immune disorders. Based on End User, the market is segmented into Research Institutes and Hospitals & Clinics. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
Free Valuable Insights: The Global RNA Based Therapeutic Market is Predict to reach $11.4 Billion by 2027, at a CAGR of 15.1%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Arbutus Biopharma Corporation, Arrowhead Pharmaceuticals, Inc., Benitec Biopharma, Inc., Alnylam Pharmaceuticals, Inc., Sanofi S.A. (Sanofi Genzyme), Biogen, Inc., Gradalis, Inc., Ionis Pharmaceuticals, Inc., Sarepta Therapeutics, Inc., and Silence Therapeutics Plc.
Scope of the Study
Market Segments Covered in the Report:
By Type
- RNA Antisense
- RNA Interference (RNAi)
By Application
- Genetic disorders
- Auto immune disorders
By End User
- Research Institutes
- Hospitals & Clinics
By Country
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Key Market Players
List of Companies Profiled in the Report:
- Arbutus Biopharma Corporation
- Arrowhead Pharmaceuticals, Inc.
- Benitec Biopharma, Inc.
- Alnylam Pharmaceuticals, Inc.
- Sanofi S.A. (Sanofi Genzyme)
- Biogen, Inc.
- Gradalis, Inc.
- Ionis Pharmaceuticals, Inc.
- Sarepta Therapeutics, Inc.
- Silence Therapeutics Plc
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA RNA Based Therapeutic Market, by Type
1.4.2 LAMEA RNA Based Therapeutic Market, by Application
1.4.3 LAMEA RNA Based Therapeutic Market, by End User
1.4.4 LAMEA RNA Based Therapeutic Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Acquisition and Mergers
3.2.3 Approvals and Trials
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2017-2021)
3.3.2 Key Strategic Move: (Partnerships, Collaborations and Agreements: 2017, Apr – 2022, Jan) Leading Players
Chapter 4. LAMEA RNA Based Therapeutic Market by Type
4.1 LAMEA RNA Antisense Market by Country
4.2 LAMEA RNA Interference (RNAi) Market by Country
Chapter 5. LAMEA RNA Based Therapeutic Market by Application
5.1 LAMEA Genetic disorders Market by Country
5.2 LAMEA Auto immune disorders Market by Country
Chapter 6. LAMEA RNA Based Therapeutic Market by End User
6.1 LAMEA Research Institutes Market by Country
6.2 LAMEA Hospitals & Clinics Market by Country
Chapter 7. LAMEA RNA Based Therapeutic Market by Country
7.1 Brazil RNA Based Therapeutic Market
7.1.1 Brazil RNA Based Therapeutic Market by Type
7.1.2 Brazil RNA Based Therapeutic Market by Application
7.1.3 Brazil RNA Based Therapeutic Market by End User
7.2 Argentina RNA Based Therapeutic Market
7.2.1 Argentina RNA Based Therapeutic Market by Type
7.2.2 Argentina RNA Based Therapeutic Market by Application
7.2.3 Argentina RNA Based Therapeutic Market by End User
7.3 UAE RNA Based Therapeutic Market
7.3.1 UAE RNA Based Therapeutic Market by Type
7.3.2 UAE RNA Based Therapeutic Market by Application
7.3.3 UAE RNA Based Therapeutic Market by End User
7.4 Saudi Arabia RNA Based Therapeutic Market
7.4.1 Saudi Arabia RNA Based Therapeutic Market by Type
7.4.2 Saudi Arabia RNA Based Therapeutic Market by Application
7.4.3 Saudi Arabia RNA Based Therapeutic Market by End User
7.5 South Africa RNA Based Therapeutic Market
7.5.1 South Africa RNA Based Therapeutic Market by Type
7.5.2 South Africa RNA Based Therapeutic Market by Application
7.5.3 South Africa RNA Based Therapeutic Market by End User
7.6 Nigeria RNA Based Therapeutic Market
7.6.1 Nigeria RNA Based Therapeutic Market by Type
7.6.2 Nigeria RNA Based Therapeutic Market by Application
7.6.3 Nigeria RNA Based Therapeutic Market by End User
7.7 Rest of LAMEA RNA Based Therapeutic Market
7.7.1 Rest of LAMEA RNA Based Therapeutic Market by Type
7.7.2 Rest of LAMEA RNA Based Therapeutic Market by Application
7.7.3 Rest of LAMEA RNA Based Therapeutic Market by End User
Chapter 8. Company Profiles
8.1 Arbutus Biopharma Corporation
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Research & Development Expenses
8.1.4 Recent strategies and developments:
8.1.4.1 Partnerships, Collaborations, and Agreements:
8.1.4.2 Acquisitions, Mergers and Joint Ventures:
8.2 Arrowhead Pharmaceuticals, Inc.
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Research & Development Expenses
8.2.4 Recent strategies and developments:
8.2.4.1 Partnerships, Collaborations, and Agreements:
8.3 Benitec Biopharma, Inc.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Research & Development Expenses
8.4 Alnylam Pharmaceuticals, Inc.
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Research & Development Expense
8.4.4 Recent strategies and developments:
8.4.4.1 Partnerships, Collaborations, and Agreements:
8.4.4.2 Approvals and Trials:
8.5 Sanofi S.A. (Sanofi Genzyme)
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research & Development Expense
8.5.5 Recent strategies and developments:
8.5.5.1 Partnerships, Collaborations, and Agreements:
8.5.5.2 Acquisition and Mergers:
8.6 Biogen, Inc.
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Regional Analysis
8.6.4 Research & Development Expense
8.6.5 Recent strategies and developments:
8.6.5.1 Partnerships, Collaborations, and Agreements:
8.7 Gradalis, Inc.
8.7.1 Company Overview
8.8 Ionis Pharmaceuticals, Inc.
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Segmental Analysis
8.8.4 Research & Development Expenses
8.8.5 Recent strategies and developments:
8.8.5.1 Partnerships, Collaborations, and Agreements:
8.9 Sarepta Therapeutics, Inc.
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Research & Development Expenses
8.9.4 Recent strategies and developments:
8.9.4.1 Partnerships, Collaborations, and Agreements:
8.10. Silence Therapeutics Plc
8.10.1 Company Overview
8.10.2 Financial Analysis
8.10.3 Research & Development Expenses
8.10.4 Recent strategies and developments:
8.10.4.1 Partnerships, Collaborations, and Agreements:
TABLE 1 LAMEA RNA Based Therapeutic Market, 2017 - 2020, USD Million
TABLE 2 LAMEA RNA Based Therapeutic Market, 2021 - 2027, USD Million
TABLE 3 Partnerships, Collaborations and Agreements– RNA Based Therapeutic Market
TABLE 4 Acquisition and Mergers– RNA Based Therapeutic Market
TABLE 5 Approvals and trials– RNA Based Therapeutic Market
TABLE 6 LAMEA RNA Based Therapeutic Market by Type, 2017 - 2020, USD Million
TABLE 7 LAMEA RNA Based Therapeutic Market by Type, 2021 - 2027, USD Million
TABLE 8 LAMEA RNA Antisense Market by Country, 2017 - 2020, USD Million
TABLE 9 LAMEA RNA Antisense Market by Country, 2021 - 2027, USD Million
TABLE 10 LAMEA RNA Interference (RNAi) Market by Country, 2017 - 2020, USD Million
TABLE 11 LAMEA RNA Interference (RNAi) Market by Country, 2021 - 2027, USD Million
TABLE 12 LAMEA RNA Based Therapeutic Market by Application, 2017 - 2020, USD Million
TABLE 13 LAMEA RNA Based Therapeutic Market by Application, 2021 - 2027, USD Million
TABLE 14 LAMEA Genetic disorders Market by Country, 2017 - 2020, USD Million
TABLE 15 LAMEA Genetic disorders Market by Country, 2021 - 2027, USD Million
TABLE 16 LAMEA Auto immune disorders Market by Country, 2017 - 2020, USD Million
TABLE 17 LAMEA Auto immune disorders Market by Country, 2021 - 2027, USD Million
TABLE 18 LAMEA RNA Based Therapeutic Market by End User, 2017 - 2020, USD Million
TABLE 19 LAMEA RNA Based Therapeutic Market by End User, 2021 - 2027, USD Million
TABLE 20 LAMEA Research Institutes Market by Country, 2017 - 2020, USD Million
TABLE 21 LAMEA Research Institutes Market by Country, 2021 - 2027, USD Million
TABLE 22 LAMEA Hospitals & Clinics Market by Country, 2017 - 2020, USD Million
TABLE 23 LAMEA Hospitals & Clinics Market by Country, 2021 - 2027, USD Million
TABLE 24 LAMEA RNA Based Therapeutic Market by Country, 2017 - 2020, USD Million
TABLE 25 LAMEA RNA Based Therapeutic Market by Country, 2021 - 2027, USD Million
TABLE 26 Brazil RNA Based Therapeutic Market, 2017 - 2020, USD Million
TABLE 27 Brazil RNA Based Therapeutic Market, 2021 - 2027, USD Million
TABLE 28 Brazil RNA Based Therapeutic Market by Type, 2017 - 2020, USD Million
TABLE 29 Brazil RNA Based Therapeutic Market by Type, 2021 - 2027, USD Million
TABLE 30 Brazil RNA Based Therapeutic Market by Application, 2017 - 2020, USD Million
TABLE 31 Brazil RNA Based Therapeutic Market by Application, 2021 - 2027, USD Million
TABLE 32 Brazil RNA Based Therapeutic Market by End User, 2017 - 2020, USD Million
TABLE 33 Brazil RNA Based Therapeutic Market by End User, 2021 - 2027, USD Million
TABLE 34 Argentina RNA Based Therapeutic Market, 2017 - 2020, USD Million
TABLE 35 Argentina RNA Based Therapeutic Market, 2021 - 2027, USD Million
TABLE 36 Argentina RNA Based Therapeutic Market by Type, 2017 - 2020, USD Million
TABLE 37 Argentina RNA Based Therapeutic Market by Type, 2021 - 2027, USD Million
TABLE 38 Argentina RNA Based Therapeutic Market by Application, 2017 - 2020, USD Million
TABLE 39 Argentina RNA Based Therapeutic Market by Application, 2021 - 2027, USD Million
TABLE 40 Argentina RNA Based Therapeutic Market by End User, 2017 - 2020, USD Million
TABLE 41 Argentina RNA Based Therapeutic Market by End User, 2021 - 2027, USD Million
TABLE 42 UAE RNA Based Therapeutic Market, 2017 - 2020, USD Million
TABLE 43 UAE RNA Based Therapeutic Market, 2021 - 2027, USD Million
TABLE 44 UAE RNA Based Therapeutic Market by Type, 2017 - 2020, USD Million
TABLE 45 UAE RNA Based Therapeutic Market by Type, 2021 - 2027, USD Million
TABLE 46 UAE RNA Based Therapeutic Market by Application, 2017 - 2020, USD Million
TABLE 47 UAE RNA Based Therapeutic Market by Application, 2021 - 2027, USD Million
TABLE 48 UAE RNA Based Therapeutic Market by End User, 2017 - 2020, USD Million
TABLE 49 UAE RNA Based Therapeutic Market by End User, 2021 - 2027, USD Million
TABLE 50 Saudi Arabia RNA Based Therapeutic Market, 2017 - 2020, USD Million
TABLE 51 Saudi Arabia RNA Based Therapeutic Market, 2021 - 2027, USD Million
TABLE 52 Saudi Arabia RNA Based Therapeutic Market by Type, 2017 - 2020, USD Million
TABLE 53 Saudi Arabia RNA Based Therapeutic Market by Type, 2021 - 2027, USD Million
TABLE 54 Saudi Arabia RNA Based Therapeutic Market by Application, 2017 - 2020, USD Million
TABLE 55 Saudi Arabia RNA Based Therapeutic Market by Application, 2021 - 2027, USD Million
TABLE 56 Saudi Arabia RNA Based Therapeutic Market by End User, 2017 - 2020, USD Million
TABLE 57 Saudi Arabia RNA Based Therapeutic Market by End User, 2021 - 2027, USD Million
TABLE 58 South Africa RNA Based Therapeutic Market, 2017 - 2020, USD Million
TABLE 59 South Africa RNA Based Therapeutic Market, 2021 - 2027, USD Million
TABLE 60 South Africa RNA Based Therapeutic Market by Type, 2017 - 2020, USD Million
TABLE 61 South Africa RNA Based Therapeutic Market by Type, 2021 - 2027, USD Million
TABLE 62 South Africa RNA Based Therapeutic Market by Application, 2017 - 2020, USD Million
TABLE 63 South Africa RNA Based Therapeutic Market by Application, 2021 - 2027, USD Million
TABLE 64 South Africa RNA Based Therapeutic Market by End User, 2017 - 2020, USD Million
TABLE 65 South Africa RNA Based Therapeutic Market by End User, 2021 - 2027, USD Million
TABLE 66 Nigeria RNA Based Therapeutic Market, 2017 - 2020, USD Million
TABLE 67 Nigeria RNA Based Therapeutic Market, 2021 - 2027, USD Million
TABLE 68 Nigeria RNA Based Therapeutic Market by Type, 2017 - 2020, USD Million
TABLE 69 Nigeria RNA Based Therapeutic Market by Type, 2021 - 2027, USD Million
TABLE 70 Nigeria RNA Based Therapeutic Market by Application, 2017 - 2020, USD Million
TABLE 71 Nigeria RNA Based Therapeutic Market by Application, 2021 - 2027, USD Million
TABLE 72 Nigeria RNA Based Therapeutic Market by End User, 2017 - 2020, USD Million
TABLE 73 Nigeria RNA Based Therapeutic Market by End User, 2021 - 2027, USD Million
TABLE 74 Rest of LAMEA RNA Based Therapeutic Market, 2017 - 2020, USD Million
TABLE 75 Rest of LAMEA RNA Based Therapeutic Market, 2021 - 2027, USD Million
TABLE 76 Rest of LAMEA RNA Based Therapeutic Market by Type, 2017 - 2020, USD Million
TABLE 77 Rest of LAMEA RNA Based Therapeutic Market by Type, 2021 - 2027, USD Million
TABLE 78 Rest of LAMEA RNA Based Therapeutic Market by Application, 2017 - 2020, USD Million
TABLE 79 Rest of LAMEA RNA Based Therapeutic Market by Application, 2021 - 2027, USD Million
TABLE 80 Rest of LAMEA RNA Based Therapeutic Market by End User, 2017 - 2020, USD Million
TABLE 81 Rest of LAMEA RNA Based Therapeutic Market by End User, 2021 - 2027, USD Million
TABLE 82 Key information – Arbutus Biopharma Corporation
TABLE 83 Key information – Arrowhead Pharmaceuticals, Inc.
TABLE 84 Key information – Benitec Biopharma, Inc.
TABLE 85 Key Information – Alnylam Pharmaceuticals, Inc.
TABLE 86 Key Information – Sanofi S.A.
TABLE 87 Key Information – Biogen, Inc.
TABLE 88 Key information – Gradalis, Inc.
TABLE 89 Key information – Ionis Pharmaceuticals, Inc.
TABLE 90 Key information – Sarepta Therapeutics, Inc.
TABLE 91 Key information – Silence Therapeutics plc
List of Figures
FIG 1 Methodology for the research
FIG 1 KBV Cardinal Matrix
FIG 2 Key Leading Strategies: Percentage Distribution (2017-2021)
FIG 3 Key Strategic Move: (Partnerships, Collaborations and Agreements: 2017, Apr – 2022, Jan) Leading Players
FIG 4 Recent strategies and developments: Arbutus Biopharma Corporation
FIG 5 Recent strategies and developments: Sanofi S.A.